Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D9226
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 187 $1,228,594 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $1,228,594 Current and potential, with all options
- Last date to order 10% complete
- IDV ceiling 25% used
- $4,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV award SPE2DR25D9226 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $499,999,999, covers a comprehensive range of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide.
The original solicitation, planned for release in March 2024, is for the DLA Troop Support Medical Supply Chain's Pharmaceutical Prime Vendor Global Program Generation V contracts. The contracts will have a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. The solicitation aims to establish multiple primary supplier awards for separate regions (North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet) as well as a single backup supplier award, with the intention of diversifying the Department of Defense's pharmaceutical supply chain to increase resiliency during contingencies or natural disasters. The contract will be awarded on a lowest price technically acceptable basis, with the option to utilize a reverse auction process to determine the final distribution fees.
Task orders
Show 40 more
Latest 50 of 187 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DR25D9226?
SPE2DR25D9226 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 1, 2025.
How much is contract SPE2DR25D9226 worth?
Orders under SPE2DR25D9226 have obligated $1,228,594. SPE2DR25D9226's own ceiling is $4,999,999.
How many orders have been placed under contract SPE2DR25D9226?
187 orders have been placed under SPE2DR25D9226, the latest on July 29, 2026.
Who can order from contract SPE2DR25D9226?
SPE2DR25D9226 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D9226 competed?
The extent of competition for SPE2DR25D9226 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV